Nov 10 (Reuters) – Danish drugmaker Lundbeck raised its full-year sales and profit forecasts on Tuesday after third-quarter earnings beat expectations, citing strong demand for its migraine treatment
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Nov 10 (Reuters) - Nvidia CEO Jensen Huang's affair with a Chinese businesswoman alleged to…
By Ross Kerber Nov 10 (Reuters) - Revelations that Nvidia CEO Jensen Huang had an…
ANTHROPIC: A DONOR-ADVISED FUND ESTABLISHED BY REED HASTINGS INDICATED INTEREST IN PURCHASING CLASS A STOCK…
Nov 10 (Reuters) - Stora Enso Oyj: * STORA ENSO CONCLUDES STRATEGIC REVIEW FOR CENTRAL…
By Echo Wang Nov 10 (Reuters) - Anthropic's IPO is set to raise as much…
By Echo Wang Nov 10 (Reuters) - Anthropic's IPO is set to raise as much…